Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluarix Tetra Immunogenicity and Safety in Adults (2013/2014)
NCT01878812Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2013
- Primary completion
- Aug 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Fluarix Quadrivalent in influenza, sponsored by GSK. Started Jul 2013; status: completed.
02
Drugs
Fluarix Quadrivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01878812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01878812.